Intrepid Potash (IPI)
(Delayed Data from NYSE)
$19.60 USD
-0.13 (-0.66%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $19.59 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IPI 19.60 -0.13(-0.66%)
Will IPI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IPI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IPI
Nutrien (NTR) Gains on Strong Demand Amid Pricing Woes
Zacks Industry Outlook Highlights CF Industries, ICL Group and Intrepid Potash
IPI: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Fertilizer Stocks to Watch Amid Industry Headwinds
Intrepid Potash (IPI) Q4 Earnings Lag, Sales Beat Estimates
Intrepid (IPI) Enters Into Third Amendment to Agreement With XTO
Other News for IPI
Intrepid Announces Date for First Quarter 2024 Earnings Release
Intrepid Announces Medical Leave of Absence for Bob Jornayvaz; Intrepid Co-founder Hugh Harvey rejoins Board of Directors
Intrepid Potash grants temporary medical leave of absence to CEO Bob Jornayvaz
Intrepid Potash Announces Leadership Changes and Strategic Shift
Intrepid Potash grants CEO Bob Jornayvaz temporary medical leave of absence